NanoViricides Inc. (NNVC)

[Trendliner]

JUDGING DR. MOFFAT ON THE BASIS OF ONLY NUMBER OF PUBLICATIONS IS MYOPIC

In the old days much reliance was placed on how many papers were cranked out. But that's silly and misses the point. A more modern view takes into account the quality of the journals, the quality of the collaborators and very importantly how many other papers cite the work of the author in question.

Dr. Moffat is blue chip. Any other conclusion is simply wrong and reflection of looking through a biased filter. It's really that simple in this case.

Neither the good Dr. Moffat nor her findings are going to be sufficient to save the day for NNVC. But let's give credit where it is due. She deserves a standing ovation.

Gene deserves credit for picking her AND being able to convince her to attach her name to NNVC. That must have taken some real selling.

Trendliner